WHO ICTRP trial
A study of the therapeutic role of baicalin on non-alcoholic steatohepatitis by…
ChiCTR-INR-16008014 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR-INR-16008014 |
|---|---|
| Public title | A study of the therapeutic role of baicalin on non-alcoholic steatohepatitis by down-regulating the expression of miR103/107 and its mechanisms |
| Scientific title | A study of the therapeutic role of baicalin on non-alcoholic steatohepatitis by down-regulating the expression of miR103/107 and its mechanisms |
| Primary sponsor | the Central Hospital of Qingdao |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Phase | New Treatment Measure Clinical Study |
| Countries | China |
| Conditions | non-alcoholic steatohepatitis |
| Interventions | control group:Placebo;baicalin group:baicalin;metformin group,:metformin; baicalin plus metformin group: baicalin plus metformin |
| Registration date | Feb 27, 2016 |
| Target size | control group:60;baicalin group:60;metformin group,:60; baicalin plus metformin… |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: